Direct and indirect acting N-Methyl-d-Aspartate (NMDA) receptor antagonists. Drugs known to antagonize the NMDA receptor by binding to the NR1 or NR2 subunit are considered to be direct acting. Whereas, drugs that antagonize the NMDA receptor through an alternative method are considered indirect acting.